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Background
In 2007, UNAIDS and AVAC developed the Good Partici-
patory Practice (GPP) Guidelines with the aim of ensuring
community and stakeholder engagement in HIV preven-
tion research. The second edition, launched in 2011,
provides the first standardized framework for GPP compli-
ance. Five years after initial publication, it is possible and
necessary to evaluate milestones in adoption of the guide-
lines at trial site, sponsor, country, and international levels
in order to gauge progress and next steps.
Methods
A systematic review of 1) articles citing or mentioning
GPP; 2) GPP-specific trainings requested and/or carried
out by AVAC partners; 3) national and international for-
ums in which GPP was mentioned, adopted or presented
shows that GPP is gaining currency and relevance as key
in guiding not only prevention research but all research
involving human subjects.
Results
Support for and awareness of GPP have increased drama-
tically over the past five years. There is, however, a contin-
ued need for technical support for implementation.
Common gaps in practice included low levels of documen-
tation of engagement activities, planning around possible
contentious issues and trial results, and stakeholder input
in trial protocols. National level implementation activities
provided initial steps in requirement of GPP. For example,
GPP was presented to US President Obama’s Commission
for Bioethics, and subsequently cited as recommendation
for community engagement in the Commission’s official
report. This effort secured international recognition and
expanded relevance beyond HIV prevention research.
Additional action is necessary for requirement and moni-
toring of practices.
Conclusion
While stakeholder engagement has long been accepted
practice in HIV prevention research, findings from multi-
ple implementation processes suggest the value and power
of applying a systematic framework to practices. Aware-
ness of GPP has increased, however meaningful imple-
mentation within and outside of HIV prevention research
necessitates sustained commitments, new resources and
action on the part of national, international and commu-
nity-level stakeholders.
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